Pharmacokinetics, efficacy, and safety of a novel aripiprazole microsphere-based long-acting injectable formulation for schizophrenia: A multicenter, randomized controlled trial

Lignende værker

• Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen
  af: S.L. Romero Guillena, et al.
  Udgivet: (2022-06-01)
• Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia
  af: Michele Wilson, et al.
  Udgivet: (2016-03-01)
• Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies
  af: Daniel Schöttle, et al.
  Udgivet: (2022-01-01)
• Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study
  af: Marc-André Roy, et al.
  Udgivet: (2024-11-01)
• BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)
  af: Daniel Schöttle, et al.
  Udgivet: (2023-03-01)